LASS5 抗体
LASS5 适用: 人 ELISA, WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
LASS5 适用: 小鼠 ELISA, WB, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
LASS5 适用: 人, 兔, 马 WB 宿主: 兔 Polyclonal unconjugated
LASS5 抗体 by 适用
Find LASS5 抗体 for a variety of species such as anti-Mouse LASS5, anti-Human LASS5, anti-Rat LASS5. The species listed below are among those available. Click on a link to go to the corresponding products.
LASS5 抗体 by 应用范围
Find LASS5 抗体 validated for a specific application such as WB, IF (cc), IF (p), ELISA. Some of the available applications are listed below. Click on a link to go to the corresponding products.
LASS5 抗体 by 抗体来源
Find LASS5 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
LASS5 抗体 by 抗原表位
Find LASS5 抗体 with a specific epitope. The epitopes listed below are among those available. Click on a link to go to the corresponding products.
LASS5 抗体 by 克隆形成能力
Find available monoclonal or polyclonal LASS5 抗体. Click on a link to go to the corresponding products.
Popular LASS5 抗体
- (3)
- (1)
- (1)
- (1)
- (1)
- (2)
- (2)
Latest Publications for our LASS5 抗体
: "Impact of insulin deprivation and treatment on sphingolipid distribution in different muscle subcellular compartments of streptozotocin-diabetic C57Bl/6 mice." in: American journal of physiology. Endocrinology and metabolism, Vol. 306, Issue 5, pp. E529-42, (2014) (PubMed).: "Ceramide synthase 6 knockdown suppresses apoptosis after photodynamic therapy in human head and neck squamous carcinoma cells." in: Anticancer research, Vol. 32, Issue 3, pp. 753-60, (2012) (PubMed).
: "siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy." in: Anticancer research, Vol. 32, Issue 7, pp. 2479-85, (2012) (PubMed).
: "D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein ..." in: Biochimie, Vol. 93, Issue 9, pp. 1446-59, (2011) (PubMed).
: "(Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1." in: Molecular cancer research : MCR, Vol. 5, Issue 8, pp. 801-12, (2007) (PubMed).
: "Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity." in: The Journal of biological chemistry, Vol. 281, Issue 45, pp. 33931-8, (2006) (PubMed).
: "LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor." in: The Journal of biological chemistry, Vol. 280, Issue 40, pp. 33735-8, (2005) (PubMed).
: "Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors." in: The Journal of biological chemistry, Vol. 278, Issue 44, pp. 43452-9, (2003) (PubMed).
Aliases for LASS5 抗体
ceramide synthase 5 (CERS5) 抗体ceramide synthase 5 (cers5) 抗体
ceramide synthase 5 S homeolog (cers5.S) 抗体
ceramide synthase 5 (Cers5) 抗体
2310081H14Rik 抗体
AU045339 抗体
AW544927 抗体
lass5 抗体
LASS5 抗体
Lass5 抗体
trh4 抗体
Trh4 抗体